
谭勇品读医药风云
| Publishes | Daily | Episodes | 1349 | Founded | 2 years ago |
|---|---|---|---|---|---|
| Language | Number of Listeners | Categories | PhilosophySociety & CultureNewsBusiness News |

血液疾病领域可谓“全面开花”。最具代表性的莫过于CAR-T赛道。复星凯瑞的阿基仑赛注射液、合源生物的纳基奥仑赛注射液、药明巨诺的瑞基奥仑赛注射液、驯鹿生物的伊基奥仑赛注射液以及科济药业(恺兴生命科技)的泽沃基奥仑赛注射液等5款CAR-T产品集体进入商保创新药目录,为2025年的创新支付突破建立里程碑。除此之外,在血液肿瘤领域,多款双抗和小分子新药也成功准入基本医保和商保创新药目录。例如,在淋巴瘤领域,“罗氏打败罗氏”的戏剧性一幕再度上演。自去年罗氏的优罗华,即CD79b ADC维泊妥珠单抗成功准... more
2025年医保目录,谈判成功率、纳入数量、创新药占比皆创下新高。
今年的医保目录发布,连发布方式都不按套路来——不是在北京,而是在广州的2025创新药高质量发展大会上官宣。避开了北方的大风,发布现场带来了另一场“暖风”:经历连续八年的动态调整后,今年的医保目录更新再次用结果释放出支持真创新的信号。
数据是最直观的体现。2025年国家医保目录新增药品114种,其中一类创新药达50种。几年前,人们还称国谈是“寒冬送温暖”,而今年,这种温暖已来得更直接:谈判成功率、纳入数量、创新药占比皆创下新高。
更... more
首先,从企业层面看,多家跨国药企携“全球明星产品”成功跻身医保目录。
最典型的是近期市值突破万亿美元的礼来,其重磅产品替尔泊肽上市不到一年便成功进入目录,医保支付范围涵盖成人2型糖尿病血糖控制。今年前三季度,替尔泊肽实现全球总销售248.37亿美元,占礼来总营收近半,增速高达125%。
如今,这款全球“超级爆品”正式进入中国医保体系,其市场放量将进入加速阶段。值得注意的是,司美格鲁肽的糖尿病适应证此前已在医保内,替尔泊肽与司美格鲁肽将在医保支付框架下正面对抗。
阿斯利康则成为本次调整中跨国药企最... more
这是我们见证中国医药传奇的第十七个年份,欢迎大家莅临“2025’第十七届中国医药企业家科学家投资家大会暨海淀医药健康全产业链创新峰会”。今年大会的主题是结构性拐点。现在中国医药产业的转型升级绝非是一场寻常的转折,而是一场重新划定疆域、星河倒转的史诗级变革。第一,国内医药市场进入存量时代,过去三年规模以上企业营收下滑或持平,利润连续下降。仿制药市场断崖下跌,创新药市场缓慢上升。医院终端、零售终端、线上终端、基层终端市场和海外市场正在重新划定版图,弱者退场,强者拓疆。我们必须直面:洗牌是行业进化的铁... more
主播内容很好,但普通话程度不易听懂。建议使用AI阅读或找个普通话标准的人播音
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #67 | |
Apple Podcasts | #185 |
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | Gender Skew | Location | |||
|---|---|---|---|---|---|
| Interests | Professions | Age Range | |||
| Household Income | Social Media Reach | ||||
Rephonic provides a wide range of podcast stats for 谭勇品读医药风云. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to 谭勇品读医药风云 and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for 谭勇品读医药风云, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for 谭勇品读医药风云, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers 谭勇品读医药风云 has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with 谭勇品读医药风云:
谭勇品读医药风云 launched 2 years ago and published 1349 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for 谭勇品读医药风云 from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of 谭勇品读医药风云. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.